tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LRMR Stock Latest News

Larimar Therapeutics price target raised to $13 from $12 at Wedbush
The FlyLarimar Therapeutics price target raised to $13 from $12 at Wedbush
9h ago
LRMR
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
PremiumRatings
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
1d ago
LRMR
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
PremiumThe Fly
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
1d ago
LRMR
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4d ago
LRMR
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
PremiumCompany Announcements
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
11d ago
8K
LRMR
Larimar Therapeutics price target raised to $12 from $11 at Wedbush
PremiumThe FlyLarimar Therapeutics price target raised to $12 from $11 at Wedbush
17d ago
LRMR
Larimar Therapeutics Announces Upsized Public Equity Offering
Premium
Company Announcements
Larimar Therapeutics Announces Upsized Public Equity Offering
21d ago
8K
LRMR
Larimar Therapeutics 20M share Spot Secondary priced at $5.00
Premium
The Fly
Larimar Therapeutics 20M share Spot Secondary priced at $5.00
23d ago
LRMR
Larimar Therapeutics $75M Spot Secondary price range $4.75-$5.25
PremiumThe Fly
Larimar Therapeutics $75M Spot Secondary price range $4.75-$5.25
23d ago
LRMR
Larimar Therapeutics price target raised to $14 from $12 at Citi
PremiumThe Fly
Larimar Therapeutics price target raised to $14 from $12 at Citi
23d ago
LRMR
Midday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
PremiumThe Fly
Midday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
24d ago
HD
AMD
Larimar Therapeutics announces FDA granted BTD to nomlabofusp
PremiumThe Fly
Larimar Therapeutics announces FDA granted BTD to nomlabofusp
24d ago
LRMR
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
PremiumCompany AnnouncementsFDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
24d ago
8K
LRMR
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
Premium
Company Announcements
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
2M ago
LRMR
Larimar Therapeutics executes preferred stock exchange and amendment
Premium
Company Announcements
Larimar Therapeutics executes preferred stock exchange and amendment
2M ago
8K
LRMR
Larimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
PremiumCompany Announcements
Larimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
2M ago
8K
LRMR
Larimar Therapeutics Executes Strategic Stock Exchange Agreement
PremiumCompany Announcements
Larimar Therapeutics Executes Strategic Stock Exchange Agreement
3M ago
8K
LRMR
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
PremiumCompany Announcements
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
4M ago
8K
LRMR
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
PremiumCompany Announcements
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
4M ago
LRMR
Buy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
PremiumRatingsBuy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
5M ago
LRMR
Positive Outlook for Larimar Therapeutics Amidst Regulatory Challenges: Buy Rating Justified
Premium
Ratings
Positive Outlook for Larimar Therapeutics Amidst Regulatory Challenges: Buy Rating Justified
5M ago
LRMR
Larimar Therapeutics reports Q3 EPS (61c), consensus (42c)
Premium
The Fly
Larimar Therapeutics reports Q3 EPS (61c), consensus (42c)
5M ago
LRMR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >